ModivCare Statistics
Share Statistics
ModivCare has 14.35M
shares outstanding. The number of shares has increased by 0.91%
in one year.
Shares Outstanding | 14.35M |
Shares Change (YoY) | 0.91% |
Shares Change (QoQ) | 0.39% |
Owned by Institutions (%) | 99.99% |
Shares Floating | n/a |
Failed to Deliver (FTD) Shares | 49,892 |
FTD / Avg. Volume | 10.37% |
Short Selling Information
The latest short interest is 2.72M, so 18.98% of the outstanding
shares have been sold short.
Short Interest | 2.72M |
Short % of Shares Out | 18.98% |
Short % of Float | 44.99% |
Short Ratio (days to cover) | 4.17 |
Valuation Ratios
The PE ratio is -0.84 and the forward
PE ratio is 1.9.
ModivCare's PEG ratio is
0.42.
PE Ratio | -0.84 |
Forward PE | 1.9 |
PS Ratio | 0.06 |
Forward PS | 0 |
PB Ratio | -4.38 |
P/FCF Ratio | -4.95 |
PEG Ratio | 0.42 |
Financial Ratio History Enterprise Valuation
Currently the Enterprise Value (EV) is not available for ModivCare.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.79,
with a Debt / Equity ratio of -33.85.
Current Ratio | 0.79 |
Quick Ratio | 0.79 |
Debt / Equity | -33.85 |
Debt / EBITDA | 266.79 |
Debt / FCF | -38.26 |
Interest Coverage | -0.99 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $117,743.86 |
Profits Per Employee | $-8,501.71 |
Employee Count | 23,675 |
Asset Turnover | 1.69 |
Inventory Turnover | n/a |
Taxes
Income Tax | -5.51M |
Effective Tax Rate | 2.77% |
Stock Price Statistics
The stock price has increased by -95.3% in the
last 52 weeks. The beta is 0.89, so ModivCare's
price volatility has been higher than the market average.
Beta | 0.89 |
52-Week Price Change | -95.3% |
50-Day Moving Average | 1.72 |
200-Day Moving Average | 11.92 |
Relative Strength Index (RSI) | 41.89 |
Average Volume (20 Days) | 481,236 |
Income Statement
In the last 12 months, ModivCare had revenue of 2.79B
and earned -201.28M
in profits. Earnings per share was -14.14.
Revenue | 2.79B |
Gross Profit | 420.37M |
Operating Income | -92.79M |
Net Income | -201.28M |
EBITDA | 4.88M |
EBIT | -104.58M |
Earnings Per Share (EPS) | -14.14 |
Full Income Statement Balance Sheet
The company has 112.58M in cash and 1.3B in
debt, giving a net cash position of -1.19B.
Cash & Cash Equivalents | 112.58M |
Total Debt | 1.3B |
Net Cash | -1.19B |
Retained Earnings | -225.72M |
Total Assets | 1.65B |
Working Capital | -129.12M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -6.41M
and capital expenditures -27.63M, giving a free cash flow of -34.04M.
Operating Cash Flow | -6.41M |
Capital Expenditures | -27.63M |
Free Cash Flow | -34.04M |
FCF Per Share | -2.39 |
Full Cash Flow Statement Margins
Gross margin is 15.08%, with operating and profit margins of -3.33% and -7.22%.
Gross Margin | 15.08% |
Operating Margin | -3.33% |
Pretax Margin | -7.13% |
Profit Margin | -7.22% |
EBITDA Margin | 0.18% |
EBIT Margin | -3.33% |
FCF Margin | -1.22% |